Track the SBC Medical Group Holdings Inc stock price and the full directors' dealings record of the company, a listed equity based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). Market capitalisation: €394m. The latest transaction was disclosed on 29 April 2026 (Cession). Among the most active insiders: Aikawa Yoshiyuki. The full history is free.
6
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€17m
3 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate SBC Medical Group Holdings Inc Strong Buy (bullish), based on 4 analysts. Average price target: US$8.50.
55Σ signal
Buys n/a€17m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 674 of 29,064 companies
83.3
score / 100
Value
82
Quality
85
FCF yld5.1%
Earn yld12%
EV/EBITDA5.6x
ROE19%
Gross mgn73%
Net mgn29%
Debt/EBITDA0.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
1,503,473 shares0Common Stock, par value $0.0001 per shareSEC:0001213900-24-079606:0
6 of 6 declarations
Acerca de SBC Medical Group Holdings Inc
SBC Medical Group Holdings Inc es una empresa que cotiza en el mercado XNAS. Está involucrada en el sector médico, aunque no se proporcionan más detalles sobre sus actividades específicas.